| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | AGAP5 STARD8 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 PREX2 RASAL1 ASAP1 AGAP1 AGAP3 | 2.26e-10 | 279 | 70 | 12 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RASGRP4 AGAP5 STARD8 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 PREX2 RASAL1 ASAP1 AGAP1 AGAP3 | 1.98e-08 | 507 | 70 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RASGRP4 AGAP5 STARD8 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 PREX2 RASAL1 ASAP1 AGAP1 AGAP3 | 1.98e-08 | 507 | 70 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | lipid binding | RASGRP4 AGAP5 SCAP STARD8 DEFB119 SLC22A2 RNF34 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 RPH3A RASAL1 ASAP1 AGAP1 ITPR1 | 3.67e-08 | 988 | 70 | 17 | GO:0008289 |
| GeneOntologyMolecularFunction | phospholipid binding | AGAP5 RNF34 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 RPH3A RASAL1 ASAP1 AGAP1 ITPR1 | 4.04e-07 | 548 | 70 | 12 | GO:0005543 |
| GeneOntologyMolecularFunction | enzyme activator activity | AGAP5 STARD8 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 PREX2 RASAL1 ASAP1 AGAP1 AGAP3 | 2.66e-06 | 656 | 70 | 12 | GO:0008047 |
| GeneOntologyMolecularFunction | P-type divalent copper transporter activity | 1.21e-05 | 2 | 70 | 2 | GO:0043682 | |
| GeneOntologyMolecularFunction | P-type monovalent copper transporter activity | 1.21e-05 | 2 | 70 | 2 | GO:0140581 | |
| GeneOntologyMolecularFunction | GTPase activity | 2.50e-05 | 341 | 70 | 8 | GO:0003924 | |
| GeneOntologyMolecularFunction | propionate-CoA ligase activity | 7.24e-05 | 4 | 70 | 2 | GO:0050218 | |
| GeneOntologyMolecularFunction | short-chain fatty acid-CoA ligase activity | 7.24e-05 | 4 | 70 | 2 | GO:0031955 | |
| GeneOntologyMolecularFunction | acetate-CoA ligase activity | 7.24e-05 | 4 | 70 | 2 | GO:0003987 | |
| GeneOntologyMolecularFunction | GTP binding | 7.32e-05 | 397 | 70 | 8 | GO:0005525 | |
| GeneOntologyMolecularFunction | molecular function activator activity | IL10 AGAP5 STARD8 STC2 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 PREX2 RASAL1 ASAP1 AGAP1 AGAP3 | 8.08e-05 | 1233 | 70 | 14 | GO:0140677 |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 1.47e-04 | 439 | 70 | 8 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 1.47e-04 | 439 | 70 | 8 | GO:0019001 | |
| GeneOntologyMolecularFunction | copper ion transmembrane transporter activity | 3.35e-04 | 8 | 70 | 2 | GO:0005375 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | RASGRP4 AGAP5 STARD8 AGAP11 AGAP9 AGAP7P BIRC6 AGAP4 AGAP6 PREX2 RASAL1 ASAP1 AGAP1 AGAP3 | 3.48e-04 | 1418 | 70 | 14 | GO:0030234 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | AGAP5 ATP7A ATP7B AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 AGAP1 AGAP3 | 3.53e-04 | 775 | 70 | 10 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | AGAP5 ATP7A ATP7B AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 AGAP1 AGAP3 | 6.56e-04 | 839 | 70 | 10 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | AGAP5 ATP7A ATP7B AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 AGAP1 AGAP3 | 6.62e-04 | 840 | 70 | 10 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | AGAP5 ATP7A ATP7B AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 AGAP1 AGAP3 | 6.62e-04 | 840 | 70 | 10 | GO:0016818 |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 1.07e-03 | 14 | 70 | 2 | GO:0070679 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 1.41e-03 | 16 | 70 | 2 | GO:0015385 | |
| GeneOntologyMolecularFunction | AMP binding | 2.44e-03 | 21 | 70 | 2 | GO:0016208 | |
| GeneOntologyMolecularFunction | fatty acid ligase activity | 3.73e-03 | 26 | 70 | 2 | GO:0015645 | |
| GeneOntologyMolecularFunction | cullin family protein binding | 3.73e-03 | 26 | 70 | 2 | GO:0097602 | |
| GeneOntologyMolecularFunction | CoA-ligase activity | 4.02e-03 | 27 | 70 | 2 | GO:0016405 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 4.02e-03 | 27 | 70 | 2 | GO:0051139 | |
| GeneOntologyMolecularFunction | acid-thiol ligase activity | 5.28e-03 | 31 | 70 | 2 | GO:0016878 | |
| GeneOntologyMolecularFunction | alcohol binding | 5.53e-03 | 102 | 70 | 3 | GO:0043178 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | 3.00e-09 | 109 | 69 | 8 | GO:0090630 | |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | AGAP5 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 PREX2 ASAP1 AGAP1 AGAP3 | 8.23e-09 | 244 | 69 | 10 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | AGAP5 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 PREX2 RASAL1 ASAP1 AGAP1 AGAP3 | 1.39e-08 | 335 | 69 | 11 | GO:0043087 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | AGAP5 SLC22A2 RNF34 AGAP11 AGAP9 AGAP7P BIRC6 AGAP4 AGAP6 NOS3 PREX2 RASAL1 ASAP1 AGAP1 AGAP3 | 1.60e-07 | 878 | 69 | 15 | GO:0051336 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | AGAP5 SLC22A2 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 PREX2 ASAP1 AGAP1 AGAP3 | 7.65e-07 | 499 | 69 | 11 | GO:0051345 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | AGAP5 ATP7A ADRB3 SLC22A2 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 NOS3 PREX2 ADCY8 ASAP1 AGAP1 AGAP3 | 1.18e-06 | 1028 | 69 | 15 | GO:0043085 |
| GeneOntologyBiologicalProcess | propionate biosynthetic process | 1.10e-05 | 2 | 69 | 2 | GO:0019542 | |
| GeneOntologyBiologicalProcess | acetate biosynthetic process | 1.10e-05 | 2 | 69 | 2 | GO:0019413 | |
| GeneOntologyBiologicalProcess | acetyl-CoA biosynthetic process from acetate | 1.10e-05 | 2 | 69 | 2 | GO:0019427 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | IL10 AGAP5 ATP7A ADRB3 SLC22A2 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 NOS3 PREX2 ADCY8 ASAP1 AGAP1 AGAP3 | 1.50e-05 | 1430 | 69 | 16 | GO:0044093 |
| GeneOntologyBiologicalProcess | copper ion export | 3.30e-05 | 3 | 69 | 2 | GO:0060003 | |
| GeneOntologyBiologicalProcess | short-chain fatty acid biosynthetic process | 6.59e-05 | 4 | 69 | 2 | GO:0051790 | |
| GeneOntologyBiologicalProcess | acetate metabolic process | 6.59e-05 | 4 | 69 | 2 | GO:0006083 | |
| GeneOntologyBiologicalProcess | regulation of superoxide dismutase activity | 1.10e-04 | 5 | 69 | 2 | GO:1901668 | |
| GeneOntologyBiologicalProcess | propionate metabolic process | 1.10e-04 | 5 | 69 | 2 | GO:0019541 | |
| GeneOntologyBiologicalProcess | copper ion import | 3.91e-04 | 9 | 69 | 2 | GO:0015677 | |
| GeneOntologyBiologicalProcess | copper ion transmembrane transport | 3.91e-04 | 9 | 69 | 2 | GO:0035434 | |
| HumanPheno | Pulmonary embolism | 7.45e-06 | 43 | 16 | 4 | HP:0002204 | |
| MousePheno | fused cornea and lens | 3.23e-12 | 24 | 55 | 7 | MP:0001307 | |
| MousePheno | abnormal lens development | 2.09e-08 | 78 | 55 | 7 | MP:0005545 | |
| MousePheno | increased circulating potassium level | 2.16e-08 | 121 | 55 | 8 | MP:0005627 | |
| MousePheno | abnormal skin coloration | 3.35e-08 | 182 | 55 | 9 | MP:0011239 | |
| MousePheno | absent pinna reflex | 5.29e-08 | 89 | 55 | 7 | MP:0006358 | |
| MousePheno | abnormal pinna reflex | 1.27e-07 | 101 | 55 | 7 | MP:0001485 | |
| MousePheno | abnormal circulating potassium level | 3.18e-07 | 171 | 55 | 8 | MP:0002668 | |
| MousePheno | abnormal uvea morphology | 3.69e-07 | 241 | 55 | 9 | MP:0005197 | |
| MousePheno | abnormal snout morphology | 6.34e-07 | 257 | 55 | 9 | MP:0000443 | |
| MousePheno | abnormal iris morphology | 7.67e-07 | 192 | 55 | 8 | MP:0001322 | |
| MousePheno | abnormal potassium level | 8.97e-07 | 196 | 55 | 8 | MP:0020887 | |
| MousePheno | abnormal potassium ion homeostasis | 9.68e-07 | 198 | 55 | 8 | MP:0011978 | |
| MousePheno | abnormal anterior uvea morphology | 1.01e-06 | 199 | 55 | 8 | MP:0005194 | |
| MousePheno | cornea opacity | 2.77e-06 | 159 | 55 | 7 | MP:0001314 | |
| MousePheno | abnormal kidney copper level | 1.52e-05 | 2 | 55 | 2 | MP:0010242 | |
| MousePheno | increased kidney copper level | 1.52e-05 | 2 | 55 | 2 | MP:0010243 | |
| MousePheno | increased brain copper level | 1.52e-05 | 2 | 55 | 2 | MP:0011214 | |
| MousePheno | persistence of hyaloid vascular system | 2.53e-05 | 223 | 55 | 7 | MP:0001289 | |
| MousePheno | abnormal jaw morphology | 3.54e-05 | 530 | 55 | 10 | MP:0000454 | |
| MousePheno | decreased liver copper level | 4.55e-05 | 3 | 55 | 2 | MP:0003067 | |
| MousePheno | decreased circulating copper level | 4.55e-05 | 3 | 55 | 2 | MP:0006349 | |
| MousePheno | increased copper level | 9.07e-05 | 4 | 55 | 2 | MP:0014539 | |
| MousePheno | abnormal circulating copper level | 9.07e-05 | 4 | 55 | 2 | MP:0006348 | |
| MousePheno | abnormal viscerocranium morphology | 9.10e-05 | 593 | 55 | 10 | MP:0005274 | |
| MousePheno | decreased copper level | 1.51e-04 | 5 | 55 | 2 | MP:0014540 | |
| MousePheno | abnormal brain copper level | 1.51e-04 | 5 | 55 | 2 | MP:0011213 | |
| MousePheno | abnormal liver copper level | 2.26e-04 | 6 | 55 | 2 | MP:0003065 | |
| MousePheno | abnormal tooth morphology | 2.35e-04 | 318 | 55 | 7 | MP:0002100 | |
| MousePheno | abnormal dental arch morphology | 2.39e-04 | 319 | 55 | 7 | MP:0030254 | |
| MousePheno | abnormal circulating mineral level | IL10 AGAP5 ATP7A ATP7B P3H2 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 NOS3 AGAP1 | 3.53e-04 | 982 | 55 | 12 | MP:0006357 |
| MousePheno | abnormal auditory brainstem response | 3.75e-04 | 576 | 55 | 9 | MP:0004738 | |
| MousePheno | abnormal hearing electrophysiology | 4.70e-04 | 594 | 55 | 9 | MP:0006335 | |
| MousePheno | abnormal cornea morphology | 5.48e-04 | 366 | 55 | 7 | MP:0001312 | |
| MousePheno | abnormal copper level | 6.70e-04 | 10 | 55 | 2 | MP:0003952 | |
| MousePheno | increased circulating mineral level | 6.86e-04 | 626 | 55 | 9 | MP:0014547 | |
| MousePheno | abnormal mineral level | IL10 AGAP5 ATP7A ATP7B P3H2 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 NOS3 AGAP1 | 7.40e-04 | 1066 | 55 | 12 | MP:0000192 |
| MousePheno | abnormal mineral homeostasis | IL10 AGAP5 ATP7A ATP7B P3H2 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 NOS3 AGAP1 | 8.04e-04 | 1076 | 55 | 12 | MP:0005636 |
| MousePheno | abnormal copper homeostasis | 8.17e-04 | 11 | 55 | 2 | MP:0003951 | |
| MousePheno | alveolar process atrophy | 8.17e-04 | 11 | 55 | 2 | MP:0030466 | |
| MousePheno | abnormal hearing physiology | 8.31e-04 | 643 | 55 | 9 | MP:0001963 | |
| MousePheno | increased mineral level | 1.09e-03 | 668 | 55 | 9 | MP:0014535 | |
| MousePheno | abnormal mouth morphology | 1.11e-03 | 670 | 55 | 9 | MP:0000452 | |
| MousePheno | abnormal cranium morphology | 1.13e-03 | 813 | 55 | 10 | MP:0000438 | |
| MousePheno | abnormal craniofacial bone morphology | 1.28e-03 | 827 | 55 | 10 | MP:0002116 | |
| MousePheno | abnormal ear physiology | 1.28e-03 | 684 | 55 | 9 | MP:0003878 | |
| MousePheno | small ectoplacental cone | 1.34e-03 | 14 | 55 | 2 | MP:0002584 | |
| MousePheno | abnormal vitreous body morphology | 1.39e-03 | 429 | 55 | 7 | MP:0002699 | |
| Domain | ArfGap | 1.20e-15 | 29 | 73 | 9 | SM00105 | |
| Domain | ArfGap | 1.20e-15 | 29 | 73 | 9 | PF01412 | |
| Domain | ARFGAP | 1.20e-15 | 29 | 73 | 9 | PS50115 | |
| Domain | ArfGAP | 1.20e-15 | 29 | 73 | 9 | IPR001164 | |
| Domain | PH | AGAP5 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 PREX2 RASAL1 ASAP1 AGAP1 AGAP3 | 1.03e-08 | 278 | 73 | 11 | SM00233 |
| Domain | PH_DOMAIN | AGAP5 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 PREX2 RASAL1 ASAP1 AGAP1 AGAP3 | 1.06e-08 | 279 | 73 | 11 | PS50003 |
| Domain | PH_domain | AGAP5 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 PREX2 RASAL1 ASAP1 AGAP1 AGAP3 | 1.10e-08 | 280 | 73 | 11 | IPR001849 |
| Domain | Ankyrin_rpt-contain_dom | AGAP5 ANKRD30A AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 ASAP1 AGAP1 AGAP3 | 5.31e-08 | 254 | 73 | 10 | IPR020683 |
| Domain | ANK_REP_REGION | AGAP5 ANKRD30A AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 ASAP1 AGAP1 AGAP3 | 5.31e-08 | 254 | 73 | 10 | PS50297 |
| Domain | - | 5.14e-07 | 248 | 73 | 9 | 1.25.40.20 | |
| Domain | ANK | 5.69e-07 | 251 | 73 | 9 | SM00248 | |
| Domain | ANK_REPEAT | 6.08e-07 | 253 | 73 | 9 | PS50088 | |
| Domain | PH_dom-like | AGAP5 AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 PREX2 RASAL1 ASAP1 AGAP1 AGAP3 | 7.63e-07 | 426 | 73 | 11 | IPR011993 |
| Domain | Ankyrin_rpt | 8.14e-07 | 262 | 73 | 9 | IPR002110 | |
| Domain | Ank_2 | 1.91e-06 | 215 | 73 | 8 | PF12796 | |
| Domain | - | AGAP5 AGAP11 AGAP9 AGAP4 AGAP6 PREX2 RASAL1 ASAP1 AGAP1 AGAP3 | 2.77e-06 | 391 | 73 | 10 | 2.30.29.30 |
| Domain | PH | 3.06e-06 | 229 | 73 | 8 | PF00169 | |
| Domain | HMA_Cu_ion-bd | 1.51e-05 | 2 | 73 | 2 | IPR006122 | |
| Domain | P-typ_ATPase_IB | 1.51e-05 | 2 | 73 | 2 | IPR027256 | |
| Domain | Ac_CoA_lig | 1.51e-05 | 2 | 73 | 2 | IPR011904 | |
| Domain | Ank | 3.03e-05 | 228 | 73 | 7 | PF00023 | |
| Domain | Heavy-metal-associated_CS | 4.51e-05 | 3 | 73 | 2 | IPR017969 | |
| Domain | ACAS_N | 9.00e-05 | 4 | 73 | 2 | PF16177 | |
| Domain | ACAS_N | 9.00e-05 | 4 | 73 | 2 | IPR032387 | |
| Domain | HMA | 9.00e-05 | 4 | 73 | 2 | PF00403 | |
| Domain | HMA_2 | 9.00e-05 | 4 | 73 | 2 | PS50846 | |
| Domain | HMA_1 | 9.00e-05 | 4 | 73 | 2 | PS01047 | |
| Domain | HMA_dom | 3.12e-04 | 7 | 73 | 2 | IPR006121 | |
| Domain | Roc | 1.14e-03 | 13 | 73 | 2 | PF08477 | |
| Domain | MIRO-like | 1.14e-03 | 13 | 73 | 2 | IPR013684 | |
| Domain | Na_H_Exchanger | 1.33e-03 | 14 | 73 | 2 | PF00999 | |
| Domain | Cation/H_exchanger | 1.33e-03 | 14 | 73 | 2 | IPR006153 | |
| Domain | AMP-bd_C | 1.97e-03 | 17 | 73 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 1.97e-03 | 17 | 73 | 2 | PF13193 | |
| Domain | AMP-binding_CS | 4.61e-03 | 26 | 73 | 2 | IPR020845 | |
| Domain | - | 4.96e-03 | 27 | 73 | 2 | 2.130.10.80 | |
| Domain | AMP_BINDING | 5.33e-03 | 28 | 73 | 2 | PS00455 | |
| Domain | AMP-binding | 6.11e-03 | 30 | 73 | 2 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 6.11e-03 | 30 | 73 | 2 | IPR000873 | |
| Domain | - | 6.93e-03 | 32 | 73 | 2 | 3.40.1110.10 | |
| Domain | - | 6.93e-03 | 32 | 73 | 2 | 2.70.150.10 | |
| Domain | Gal_Oxidase_b-propeller | 7.80e-03 | 34 | 73 | 2 | IPR015916 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 2.55e-21 | 9 | 74 | 8 | 12640130 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 4.66e-20 | 11 | 74 | 8 | 15381706 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 1.76e-17 | 10 | 74 | 7 | 20664521 | |
| Pubmed | 2.50e-16 | 13 | 74 | 7 | 27713690 | ||
| Pubmed | 5.00e-16 | 14 | 74 | 7 | 22453919 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 9.02e-09 | 281 | 74 | 9 | 28706196 | |
| Pubmed | 1.83e-07 | 529 | 74 | 10 | 14621295 | ||
| Pubmed | 1.86e-07 | 116 | 74 | 6 | 30652415 | ||
| Pubmed | 3.37e-07 | 430 | 74 | 9 | 32581705 | ||
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 4.35e-07 | 218 | 74 | 7 | 33378226 | |
| Pubmed | 8.07e-07 | 80 | 74 | 5 | 19420105 | ||
| Pubmed | The genomic basis of cerebral palsy: a HuGE systematic literature review. | 8.34e-07 | 34 | 74 | 4 | 19238444 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 2.08e-06 | 536 | 74 | 9 | 15840001 | |
| Pubmed | 2.15e-06 | 538 | 74 | 9 | 10512203 | ||
| Pubmed | 2.43e-06 | 405 | 74 | 8 | 38187761 | ||
| Pubmed | Gene polymorphisms in association with emerging cardiovascular risk markers in adult women. | 3.31e-06 | 14 | 74 | 3 | 20078877 | |
| Pubmed | 3.72e-06 | 49 | 74 | 4 | 18936436 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 29394468 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 8082762 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 20730725 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19645496 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 21115196 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 21527738 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22594584 | ||
| Pubmed | Mechanisms of charge transfer in human copper ATPases ATP7A and ATP7B. | 4.47e-06 | 2 | 74 | 2 | 28164426 | |
| Pubmed | Biochemical basis of regulation of human copper-transporting ATPases. | 4.47e-06 | 2 | 74 | 2 | 17562324 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 9823011 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19330466 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 17717039 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19617323 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 20045993 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 38032054 | ||
| Pubmed | Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate. | 4.47e-06 | 2 | 74 | 2 | 11150295 | |
| Pubmed | Molecular features of copper binding proteins involved in copper homeostasis. | 4.47e-06 | 2 | 74 | 2 | 27896900 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19913857 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 15214944 | ||
| Pubmed | TGF-β/SMAD4 signaling pathway activates the HAS2-HA system to regulate granulosa cell state. | 4.47e-06 | 2 | 74 | 2 | 31489963 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28271598 | ||
| Pubmed | [Structure and function of ATP7A and ATP7B proteins--Cu-transporting ATPases]. | 4.47e-06 | 2 | 74 | 2 | 21117320 | |
| Pubmed | The 894G>T variant in the endothelial nitric oxide synthase gene and spina bifida risk. | 4.47e-06 | 2 | 74 | 2 | 17479212 | |
| Pubmed | [From gene to disease: copper-transporting P ATPases alteration]. | 4.47e-06 | 2 | 74 | 2 | 19046832 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22940147 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 10974023 | ||
| Pubmed | Expression in mouse kidney of membrane copper transporters Atp7a and Atp7b. | 4.47e-06 | 2 | 74 | 2 | 12372948 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 18565219 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 12539960 | ||
| Pubmed | Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS. | 4.47e-06 | 2 | 74 | 2 | 31916354 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 17109627 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 18688737 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 32506440 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 26187788 | ||
| Pubmed | Expression and localization of menkes and Wilson copper transporting ATPases in human placenta. | 4.47e-06 | 2 | 74 | 2 | 15135234 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 9215673 | ||
| Pubmed | Copper-transporting ATPases ATP7A and ATP7B: cousins, not twins. | 4.47e-06 | 2 | 74 | 2 | 18000748 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 30532099 | ||
| Pubmed | Glucose-independent Acetate Metabolism Promotes Melanoma Cell Survival and Tumor Growth. | 4.47e-06 | 2 | 74 | 2 | 27539851 | |
| Pubmed | Menkes disease: recent advances and new insights into copper metabolism. | 4.47e-06 | 2 | 74 | 2 | 8732640 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 21380725 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19376104 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28430047 | ||
| Pubmed | Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis. | 4.47e-06 | 2 | 74 | 2 | 17531189 | |
| Pubmed | Intracellular targeting of copper-transporting ATPase ATP7A in a normal and Atp7b-/- kidney. | 4.47e-06 | 2 | 74 | 2 | 17928409 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 21607713 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 38591127 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 21725157 | ||
| Pubmed | 5.51e-06 | 54 | 74 | 4 | 20536507 | ||
| Pubmed | 6.85e-06 | 57 | 74 | 4 | 19479237 | ||
| Pubmed | A systematic meta-analysis of genetic association studies for diabetic retinopathy. | 1.03e-05 | 20 | 74 | 3 | 19587357 | |
| Pubmed | 1.09e-05 | 64 | 74 | 4 | 19131662 | ||
| Pubmed | Candidate genes and cerebral palsy: a population-based study. | 1.20e-05 | 21 | 74 | 3 | 18977990 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 22997914 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 32382091 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 21728174 | ||
| Pubmed | Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells. | 1.34e-05 | 3 | 74 | 2 | 16043642 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 35716966 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 30842629 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 15494775 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 28737129 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 30341172 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 15634671 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 10557326 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 17551576 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 16788062 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 19049547 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 20566629 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 10497213 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 17000887 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 18602910 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 24911015 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 19349296 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 16884690 | ||
| Pubmed | Intestinal expression of metal transporters in Wilson's disease. | 1.34e-05 | 3 | 74 | 2 | 23963605 | |
| Pubmed | Association between genetic and environmental factors and the risk of Alzheimer's disease. | 1.34e-05 | 3 | 74 | 2 | 19169966 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 21169404 | ||
| Pubmed | [Endothelial dysfunction gene polymorphisms and the rate of liver fibrosis in chronic hepatitis C]. | 1.34e-05 | 3 | 74 | 2 | 24864467 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 16845248 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 21242307 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 23751120 | ||
| Pubmed | Targeting Cul3-scaffold E3 ligase complex via KLHL substrate adaptors for cancer therapy. | 1.34e-05 | 3 | 74 | 2 | 33872809 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 25095657 | ||
| Interaction | TSPAN16 interactions | 1.10e-06 | 22 | 73 | 4 | int:TSPAN16 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q11 | 2.51e-04 | 188 | 74 | 4 | chr10q11 | |
| Cytoband | 2q37 | 1.16e-03 | 31 | 74 | 2 | 2q37 | |
| Cytoband | 10q11.23 | 1.31e-03 | 33 | 74 | 2 | 10q11.23 | |
| Cytoband | 4q24 | 1.39e-03 | 34 | 74 | 2 | 4q24 | |
| Cytoband | 10q11.22 | 2.02e-03 | 41 | 74 | 2 | 10q11.22 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 6.35e-17 | 17 | 52 | 8 | 1291 | |
| GeneFamily | ArfGAPs | 2.37e-16 | 33 | 52 | 9 | 395 | |
| GeneFamily | Ankyrin repeat domain containing | AGAP5 ANKRD30A AGAP11 AGAP9 AGAP7P AGAP4 AGAP6 ASAP1 AGAP1 AGAP3 | 1.48e-09 | 242 | 52 | 10 | 403 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.54e-09 | 206 | 52 | 9 | 682 | |
| GeneFamily | ATPase copper transporting | 8.11e-06 | 2 | 52 | 2 | 1212 | |
| GeneFamily | Acyl-CoA synthetase family | 2.52e-03 | 26 | 52 | 2 | 40 | |
| GeneFamily | Solute carriers | 5.43e-03 | 395 | 52 | 5 | 752 | |
| GeneFamily | Kelch like|BTB domain containing | 6.49e-03 | 42 | 52 | 2 | 617 | |
| GeneFamily | Olfactory receptors, family 8 | 8.75e-03 | 49 | 52 | 2 | 155 | |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 8.43e-12 | 37 | 72 | 7 | MM1121 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 3.09e-11 | 44 | 72 | 7 | MM485 | |
| Coexpression | CHYLA_CBFA2T3_TARGETS_DN | 6.35e-07 | 263 | 72 | 8 | MM1295 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_DN | 1.76e-06 | 209 | 72 | 7 | MM1058 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_UP | 6.09e-05 | 77 | 72 | 4 | M4263 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-06 | 200 | 74 | 6 | 9f889f7ff0b3ba2750aa757b94680a9f7014fd0d | |
| ToppCell | Tracheal-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-06 | 200 | 74 | 6 | 71ba0e48ca4ded077f2b96a0cf4f2331f2e25d15 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_capillary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-05 | 196 | 74 | 5 | f0b106078212be1d0938f545707a004a1e830857 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 197 | 74 | 5 | c10dd1aaec01fb662eac83dfde90e3e426665d65 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 197 | 74 | 5 | 2844dbcd0a673ed81c99920aa45858651a00736d | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 74 | 5 | 06ffa5baad3e699cf66d8b2c7513649e1d2c7e62 | |
| Disease | cerebral palsy (implicated_via_orthology) | 3.33e-17 | 10 | 69 | 7 | DOID:1969 (implicated_via_orthology) | |
| Disease | occipital horn syndrome (implicated_via_orthology) | 5.39e-06 | 2 | 69 | 2 | DOID:0111272 (implicated_via_orthology) | |
| Disease | diabetic retinopathy (is_implicated_in) | 5.81e-06 | 50 | 69 | 4 | DOID:8947 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | IL10 STARD8 ATP7B STC2 MTHFR P3H2 ANKRD30A UMPS ZDHHC4 GEN1 EIF6 NOS3 | 6.61e-06 | 1074 | 69 | 12 | C0006142 |
| Disease | Diabetic Angiopathies | 6.71e-06 | 16 | 69 | 3 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 6.71e-06 | 16 | 69 | 3 | C0025945 | |
| Disease | rheumatoid arthritis (is_implicated_in) | 1.06e-05 | 58 | 69 | 4 | DOID:7148 (is_implicated_in) | |
| Disease | Mammary Carcinoma, Human | 3.07e-05 | 525 | 69 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 3.07e-05 | 525 | 69 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 3.16e-05 | 527 | 69 | 8 | C1458155 | |
| Disease | metal metabolism disorder (implicated_via_orthology) | 3.22e-05 | 4 | 69 | 2 | DOID:896 (implicated_via_orthology) | |
| Disease | aphthous stomatitis (is_implicated_in) | 3.22e-05 | 4 | 69 | 2 | DOID:9663 (is_implicated_in) | |
| Disease | Breast Carcinoma | 3.65e-05 | 538 | 69 | 8 | C0678222 | |
| Disease | Wilson disease (implicated_via_orthology) | 5.36e-05 | 5 | 69 | 2 | DOID:893 (implicated_via_orthology) | |
| Disease | Menkes disease (implicated_via_orthology) | 5.36e-05 | 5 | 69 | 2 | DOID:1838 (implicated_via_orthology) | |
| Disease | Graft-vs-Host Disease | 8.03e-05 | 6 | 69 | 2 | C0018133 | |
| Disease | coronary artery disease (is_implicated_in) | 9.07e-05 | 100 | 69 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | angle-closure glaucoma (is_implicated_in) | 1.12e-04 | 7 | 69 | 2 | DOID:13550 (is_implicated_in) | |
| Disease | colitis (biomarker_via_orthology) | 1.32e-04 | 42 | 69 | 3 | DOID:0060180 (biomarker_via_orthology) | |
| Disease | adult respiratory distress syndrome (biomarker_via_orthology) | 1.50e-04 | 8 | 69 | 2 | DOID:11394 (biomarker_via_orthology) | |
| Disease | Inflammatory disease of mucous membrane | 1.50e-04 | 8 | 69 | 2 | C0333355 | |
| Disease | spinal muscular atrophy (implicated_via_orthology) | 1.92e-04 | 9 | 69 | 2 | DOID:12377 (implicated_via_orthology) | |
| Disease | migraine (is_implicated_in) | 1.92e-04 | 9 | 69 | 2 | DOID:6364 (is_implicated_in) | |
| Disease | Thrombophilia | 1.92e-04 | 9 | 69 | 2 | C0398623 | |
| Disease | acute kidney failure (is_implicated_in) | 2.40e-04 | 10 | 69 | 2 | DOID:3021 (is_implicated_in) | |
| Disease | factor VIII deficiency (is_implicated_in) | 2.92e-04 | 11 | 69 | 2 | DOID:12134 (is_implicated_in) | |
| Disease | liver benign neoplasm (biomarker_via_orthology) | 2.92e-04 | 11 | 69 | 2 | DOID:916 (biomarker_via_orthology) | |
| Disease | Pulmonary Thromboembolisms | 3.50e-04 | 12 | 69 | 2 | C0524702 | |
| Disease | Pulmonary Embolism | 3.50e-04 | 12 | 69 | 2 | C0034065 | |
| Disease | prostatitis (biomarker_via_orthology) | 3.50e-04 | 12 | 69 | 2 | DOID:14654 (biomarker_via_orthology) | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 3.50e-04 | 12 | 69 | 2 | DOID:3319 (is_marker_for) | |
| Disease | attention function measurement | 4.08e-04 | 148 | 69 | 4 | EFO_0007636 | |
| Disease | Colonic Neoplasms | 4.51e-04 | 152 | 69 | 4 | C0009375 | |
| Disease | pulmonary hypertension (is_marker_for) | 4.60e-04 | 64 | 69 | 3 | DOID:6432 (is_marker_for) | |
| Disease | Colorectal Neoplasms | 4.84e-04 | 277 | 69 | 5 | C0009404 | |
| Disease | asthma (is_implicated_in) | 5.10e-04 | 157 | 69 | 4 | DOID:2841 (is_implicated_in) | |
| Disease | Malignant tumor of colon | 5.34e-04 | 159 | 69 | 4 | C0007102 | |
| Disease | Benign Neoplasm | 5.50e-04 | 68 | 69 | 3 | C0086692 | |
| Disease | Neoplasms | 5.50e-04 | 68 | 69 | 3 | C0027651 | |
| Disease | Hereditary Diffuse Gastric Cancer | 6.24e-04 | 293 | 69 | 5 | C1708349 | |
| Disease | atherosclerosis (is_implicated_in) | 6.33e-04 | 16 | 69 | 2 | DOID:1936 (is_implicated_in) | |
| Disease | Huntington's disease (biomarker_via_orthology) | 6.33e-04 | 16 | 69 | 2 | DOID:12858 (biomarker_via_orthology) | |
| Disease | sickle cell anemia (is_implicated_in) | 6.33e-04 | 16 | 69 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | response to acetylsalicylate | 6.33e-04 | 16 | 69 | 2 | GO_1903492 | |
| Disease | Stomach Neoplasms | 6.63e-04 | 297 | 69 | 5 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 6.94e-04 | 300 | 69 | 5 | C0024623 | |
| Disease | thrombomodulin measurement | 7.16e-04 | 17 | 69 | 2 | EFO_0007774 | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 7.16e-04 | 17 | 69 | 2 | DOID:10873 (is_implicated_in) | |
| Disease | Lipidemias | 7.16e-04 | 17 | 69 | 2 | C1706412 | |
| Disease | graft-versus-host disease (is_implicated_in) | 7.16e-04 | 17 | 69 | 2 | DOID:0081267 (is_implicated_in) | |
| Disease | Hyperlipidemia | 7.16e-04 | 17 | 69 | 2 | C0020473 | |
| Disease | sphingosine 1-phosphate measurement | 8.05e-04 | 18 | 69 | 2 | EFO_0800185 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 8.05e-04 | 18 | 69 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | hypothyroidism (biomarker_via_orthology) | 8.84e-04 | 80 | 69 | 3 | DOID:1459 (biomarker_via_orthology) | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 8.84e-04 | 80 | 69 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | inflammatory bowel disease (is_implicated_in) | 8.98e-04 | 19 | 69 | 2 | DOID:0050589 (is_implicated_in) | |
| Disease | acetate measurement | 9.96e-04 | 20 | 69 | 2 | EFO_0010112 | |
| Disease | chronic myeloid leukemia (is_implicated_in) | 1.10e-03 | 21 | 69 | 2 | DOID:8552 (is_implicated_in) | |
| Disease | mean arterial pressure | 1.11e-03 | 499 | 69 | 6 | EFO_0006340 | |
| Disease | Kidney Diseases | 1.16e-03 | 88 | 69 | 3 | C0022658 | |
| Disease | cholangiocarcinoma (is_implicated_in) | 1.21e-03 | 22 | 69 | 2 | DOID:4947 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | 1.26e-03 | 702 | 69 | 7 | C0009402 | |
| Disease | Septicemia | 1.44e-03 | 24 | 69 | 2 | C0036690 | |
| Disease | Sepsis | 1.44e-03 | 24 | 69 | 2 | C0243026 | |
| Disease | Severe Sepsis | 1.44e-03 | 24 | 69 | 2 | C1719672 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 1.44e-03 | 24 | 69 | 2 | DOID:3827 (biomarker_via_orthology) | |
| Disease | Hepatolenticular Degeneration | 1.44e-03 | 24 | 69 | 2 | C0019202 | |
| Disease | Hepatic Form of Wilson Disease | 1.44e-03 | 24 | 69 | 2 | C1527352 | |
| Disease | Pyemia | 1.44e-03 | 24 | 69 | 2 | C0034189 | |
| Disease | Myocardial Infarction | 1.45e-03 | 95 | 69 | 3 | C0027051 | |
| Disease | myocardial infarction (is_implicated_in) | 1.63e-03 | 99 | 69 | 3 | DOID:5844 (is_implicated_in) | |
| Disease | response to antineoplastic agent | 1.63e-03 | 99 | 69 | 3 | GO_0097327 | |
| Disease | Acute kidney injury | 1.73e-03 | 101 | 69 | 3 | C2609414 | |
| Disease | Acute Kidney Insufficiency | 1.73e-03 | 101 | 69 | 3 | C1565662 | |
| Disease | Kidney Failure, Acute | 1.73e-03 | 101 | 69 | 3 | C0022660 | |
| Disease | age at assessment, lateral ventricle volume change measurement | 1.82e-03 | 27 | 69 | 2 | EFO_0008007, EFO_0021502 | |
| Disease | thrombocytopenia (is_implicated_in) | 1.82e-03 | 27 | 69 | 2 | DOID:1588 (is_implicated_in) | |
| Disease | acute kidney failure (implicated_via_orthology) | 1.82e-03 | 27 | 69 | 2 | DOID:3021 (implicated_via_orthology) | |
| Disease | oral squamous cell carcinoma (is_implicated_in) | 1.96e-03 | 28 | 69 | 2 | DOID:0050866 (is_implicated_in) | |
| Disease | hyperthyroidism (biomarker_via_orthology) | 1.96e-03 | 28 | 69 | 2 | DOID:7998 (biomarker_via_orthology) | |
| Disease | stimulant use measurement | 1.96e-03 | 28 | 69 | 2 | EFO_0600076 | |
| Disease | congestive heart failure (biomarker_via_orthology) | 2.04e-03 | 107 | 69 | 3 | DOID:6000 (biomarker_via_orthology) | |
| Disease | cerebral infarction (is_implicated_in) | 2.10e-03 | 29 | 69 | 2 | DOID:3526 (is_implicated_in) | |
| Disease | chronic kidney disease | 2.26e-03 | 235 | 69 | 4 | EFO_0003884 | |
| Disease | coronary artery disease, factor VII measurement | 2.27e-03 | 111 | 69 | 3 | EFO_0001645, EFO_0004619 | |
| Disease | pancreatic cancer (is_implicated_in) | 2.32e-03 | 112 | 69 | 3 | DOID:1793 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MRIGIHSGSVLCGVL | 506 | P40145 | |
| LGVLMCIECSGIHRS | 471 | Q96P64 | |
| LGALMCIECSGIHRH | 656 | Q96P47 | |
| GVLTLGLDMSCHACL | 51 | O76042 | |
| HILLCLMGLAETPGC | 241 | Q8WV16 | |
| AMLACARIGAVHTVI | 181 | Q9NUB1 | |
| LNLGVLMCIECSGIH | 356 | Q8TF27 | |
| LMCIECSGIHRSLGT | 361 | Q8TF27 | |
| ALMCIECSGIHRNLG | 641 | Q9UPQ3 | |
| VLMCIECSGIHRSFG | 541 | Q5VTM2 | |
| LVLRDGCMHCDADGL | 56 | Q9NR09 | |
| LRIDGMHCKSCVLNI | 261 | P35670 | |
| LAVCHGSSEIVGMLL | 211 | Q9BXX3 | |
| CGLRGCVMHVNLEIE | 101 | Q96D03 | |
| CCIVVKHLGRAELGM | 246 | Q9NR19 | |
| REHRALCTLGLIMGT | 286 | P13945 | |
| LGVLMCIECSGIHRS | 471 | Q5VW22 | |
| LELVVRGMTCASCVH | 566 | Q04656 | |
| LDMHSVTGIIVGVCL | 951 | Q8TDY8 | |
| MLEDGQGRCLRCHVL | 126 | O95294 | |
| IGLVCASVHTGCMFR | 151 | Q15617 | |
| IGLICASAHIGCMFR | 186 | Q8NG78 | |
| GLETILHMTCCRQRL | 121 | P42898 | |
| MHSSALLCCLVLLTG | 1 | P22301 | |
| CETLLMCIVTVLSHG | 2536 | Q14643 | |
| MQALRHVVCALSGGV | 1 | O75648 | |
| LEDCLMVGLHTCGDL | 376 | Q8N6Q8 | |
| RLMHCVGFESILEGL | 46 | Q8N3X6 | |
| LHSLNCLMVCDIRGT | 171 | Q96MB7 | |
| MAVTGGLCHSAISRL | 291 | Q8TDF6 | |
| TVRGLHCMCTVGDKL | 481 | Q9P2J3 | |
| CRELHSVASGIMLVG | 476 | Q8IVL5 | |
| GKRHILRCMGNSGIC | 21 | Q8N690 | |
| IMGFCCSRSIHILLG | 196 | Q9Y2T6 | |
| HRVLCLERGHMFVCG | 1101 | P29474 | |
| CRIIGRMCVGNRHGL | 56 | P56537 | |
| LEMSSILRHCCDLIG | 131 | P0CF75 | |
| GLHCMCTVGERLYVI | 526 | Q9P2N7 | |
| ACGMVHLLIPELGAC | 386 | Q8N9W5 | |
| TMIGCDRLIRIFCLH | 281 | Q8NCQ5 | |
| MHCERFLCILRIIGT | 1 | Q92819 | |
| LGVLMCIECSGIHRS | 471 | Q5VUJ5 | |
| ILTCIECSGIHREMG | 471 | Q9ULH1 | |
| KSVLRECLHMLECLG | 111 | Q17RS7 | |
| GMLLVSCCLAGHVCV | 786 | Q12770 | |
| GVHICSSMCDIGGII | 466 | O15244 | |
| MVLCLLHSCLGQELS | 1031 | Q5T011 | |
| HLCGMATDLALRCLV | 266 | Q9NUP7 | |
| ICDGLRGHLMTVRSS | 51 | P07204 | |
| LCALGMLAVAICSDH | 16 | H3BS89 | |
| GLIVGIIRCVHLAAM | 566 | Q9Y2J0 | |
| GTTAMLSCLHIRVGV | 496 | Q92581 | |
| MGHALCVCSRGTVII | 1 | O75716 | |
| ICLMCVHSLERAGSK | 361 | Q9UPR3 | |
| GVVCRLSRSLQEHMG | 951 | Q6ZUX3 | |
| FCCSHLLGMVGQLER | 66 | Q7Z6Z6 | |
| LCHSLLMLAGVVVSC | 596 | Q8IXR5 | |
| CLSIVHSLMCHRQGG | 16 | Q13485 | |
| RGLLHCMVTSVREEG | 256 | Q6Q0C1 | |
| RHGLAVCLALTTMCT | 6 | Q9BVH7 | |
| MEPCGLGRSRLTHIC | 966 | Q92502 | |
| VILLMVVCSQHLGSC | 226 | Q6PIS1 | |
| VLMCIECSGIHRSLG | 496 | A6NIR3 | |
| HSLSMLGIGQCVECE | 716 | O95985 | |
| HVGNLCLVMGCITVL | 56 | Q9UKR8 | |
| VLLECGHMVTCTKCG | 336 | Q969K3 | |
| CEIRGLHGICMTFLH | 76 | O76061 | |
| VAGICSCDGRHLAVM | 1281 | O15067 | |
| MGLVLICVCSKTHSL | 16 | Q9NPG8 | |
| LHRGCLLIAEMSSTG | 361 | P11172 | |
| ICLGSGIMRDIAHLE | 146 | Q96N46 | |
| LGACHIIMCSSGVHR | 1521 | Q70Z35 | |
| IIMCSSGVHRCTLSV | 1526 | Q70Z35 | |
| MCVSAVLGSQRIGLH | 326 | Q4ZJI4 | |
| MLETCGLLVSLGHRV | 41 | Q7Z398 | |
| AHSCEMCGAILGDIL | 81 | Q8TF45 |